Navigation Links
Euclid Systems Corporation signs agreement with Wenzhou Medical University to promote the use of Orthokeratology to control myopia progression

HERNDON, Va., Sept. 11, 2013 /PRNewswire/ -- Euclid Systems Corporation today announced the signing of a cooperation agreement with Wenzhou Medical University Eye Hospital. 

"Thanks to a number of studies showing the ability of Euclid's Emerald™ brand Ortho-K lens to retard the progression (worsening) of myopia in children, the Chinese population are accepting this treatment in increasing numbers," stated Michael A Ross, MD, President and COO of Euclid.  "This strategic partnership with the Wenzhou Medical University will further enhance Euclid's reputation as the leading provider of Ortho-K lenses in China and throughout Asia."

Through this cooperative agreement, Euclid will support and assist the University in several areas, including the training of new Optometrists and Ophthalmologists in the fitting and use of Orthokeratology lenses, as well as to study of the advantages of Orthokeratology for the prevention of the progression of myopia (nearsightedness) and for treatment for high myopes (extremely nearsighted) patients.  Wenzhou University will support Euclid by presenting at Ophthalmology meetings and conferences, by being a resource for prescribing doctors throughout China, and by promoting the health benefits and care standards for Orthokeratology.  Additionally the University will work with Euclid to open an Ortho-K Trial Center on the hospital grounds as a model for prescribing doctors in China.

About Wenzhou Medical University Eye Hospital.  The Affiliated Eye Hospital of Wenzhou Medical University is a class-A specialized eye hospital and is famous for its "Wenzhou Model" of combination of optometry and ophthalmology.  The eye hospital, the chairman unit of the Chinese Optometry Association, leads the development of optometry in China.  It is also the National Optometry Center of Ministry of Public Health P.R.China and the chairman unit of International Academy Orthokeratology Asia, playing a leading role in the training, discipline development, security monitoring and organization development of Orthokeratology in China.

About Euclid Systems Corporation.  Euclid, founded in 1995, first developed and brought to market a standardized Ortho-K lens design and manufacturing process.  Euclid was the first company to apply for FDA approval, and the Emerald lens was approved by the FDA in 2004.  The Emerald lens has obtained regulatory approval from the appropriate governing bodies in multiple international markets.  Additionally, Euclid is involved in a number of research projects investigating corneal stabilization.

SOURCE Euclid Systems Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sentry Data Systems Expands Support Organization To Address Pharmacy Procurement Management And Compliance Needs
2. Absorption Systems Scientists Publish Peer-reviewed Paper on a Key Drug Transporter
3. National Diabetes Volunteer Leadership Council (NDVLC) Urges FDA to Enforce Stringent Accuracy Standards for Blood Glucose Monitoring Systems
4. Global Endoscopy Systems Industry
5. Global Medical Laser Systems Industry
6. Global Medical Oxygen Systems Industry
7. John Ault Appointed Director of Business Development for MedTek Systems LLC
8. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
9. Varian Medical Systems Publishes 2013 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
10. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
11. WaferGen Bio-systems Announces New Funding from Private Placement
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015  Lannett Company, ... it has completed the acquisition of Kremers Urban ... subsidiary of global biopharmaceuticals company UCB S.A. (Euronext: ... Lannett has acquired KU from UCB for ... certain adjustments, including a customary working capital adjustment, ...
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
Breaking Medicine Technology:
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... the conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved ... can help protect a patient’s overall health. The talk stressed the link between periodontal ...
(Date:11/27/2015)... ... 2015 , ... An inventor, from Hopkinsville, Ky., thought there ... home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. provides ... so, it could help to prevent potential overdose situations. As a result, it ...
(Date:11/27/2015)... LOS ANGELES, CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only ... age of 30 (see Table 1-1 ). More than 3.7 billion people under ... simplex virus type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... innovative online platform for mental health and wellness consultation, has collaborated with a ... will bridge the knowledge gap experienced by parents and bring advice from parenting ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
Breaking Medicine News(10 mins):